The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex

Addiction Biology

Volumn 19, Issue 4, 2014, Pages 612-622

  Devoto, Paola ^a,b   Flore, Giovanna ^b   Saba, Pierluigi ^a   Bini, Valentina ^a   Gessa, Gian Luigi ^a,b  

^a Department of Biomedical Sciences Neuroscience and Clinical Pharmacology Division Cittadella Universitaria   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Amphetamine; cocaine; disulfiram; microdialysis; noradrenaline; nucleus accumbens

Indexed keywords

AMPHETAMINE; CATECHOLAMINE; CLONIDINE; COCAINE; DISULFIRAM; DOPAMINE; NEPICASTAT; NORADRENALIN; PSYCHOSTIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR; IMIDAZOLE DERIVATIVE; THIOKETONE;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG MECHANISM; DRUG POTENTIATION; EXTRACELLULAR MATRIX; IN VIVO STUDY; MALE; MICRODIALYSIS; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REINFORCEMENT; ANIMAL; DRUG EFFECTS; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT;

AMPHETAMINE; ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; IMIDAZOLES; MALE; MICRODIALYSIS; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; THIONES;

EID: 84904262752     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12026     Document Type: Article

References (53)

1. Altar CA, Boyar WC, Oei E, Wood PL, (1987) Dopamine autoreceptors modulate the in vivo release in the frontal, cingulate and entorhinal cortices. J Pharmacol Exp Ther 242: 115-120. (Pubitemid 17112268)
2. Bourdélat-Parks BN, Anderson GM, Donaldson ZR, Weiss JM, Bonsall RW, Emery MS, Liles LC, Weinshenker D, (2005) Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) 183: 72-80. (Pubitemid 41484184)
3. Carboni E, Tanda GL, Frau R, Di Chiara G, (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55: 1067-1070.
4. Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ, (2004) Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 61: 264-272. (Pubitemid 38295828)
5. Chiodo LA, Bannon MJ, Grace AA, Roth RH, Bunney BS, (1984) Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12: 1-16. (Pubitemid 14077673)
6. 2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J Neurochem 88: 1003-1009. (Pubitemid 38199322)
7. Devoto P, Flore G, Pira L, Longu G, Gessa GL, (2004b) Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487: 105-111. (Pubitemid 38368986)
8. Devoto P, Flore G, Saba P, Gessa GL, (2012) Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex. Psychopharmacology (Berl) 219: 1153-1164.
9. Devoto P, Flore G, Vacca G, Pira L, Arca A, Casu MA, Pani L, Gessa GL, (2003) Co-release of noradrenaline and dopamine from noradrenergic neurons in the occipital cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology (Berl) 167: 79-84. (Pubitemid 36535295)
10. Eltayb A, Wadenberg ML, Svensson TH, (2005) Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa. Biol Psychiatry 58: 337-343. (Pubitemid 41133628)
11. Galloway MP, Wolf ME, Roth RH, (1986) Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J Pharmacol Exp Ther 236: 689-698. (Pubitemid 16080067)
12. George TP, Chawarski MC, Pakes J, Carroll KM, Kosten TR, Schottenfeld RS, (2000) Disulfiram versus placebo for cocaine dependence in buprenorphine- maintained subjects: a preliminary trial. Biol Psychiatry 47: 1080-1086. (Pubitemid 30336217)
13. Gobert A, Lejeune F, Rivet JM, Cistarelli L, Millan MJ, (1996) Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo. J Neurochem 66: 2209-2212. (Pubitemid 26119677)
14. Goldstein M, Anagnoste B, Lauber E, McKeregham MR, (1964) Inhibition of dopamine-beta-hydroxylase by disulfiram. Life Sci 3: 763-767.
15. Goldstein M, Nakajima K, (1967) The effect of disulfiram on catecholamine levels in the brain. J Pharmacol Exp Ther 157: 96-102.
16. Grace AA, Floresco SB, Goto Y, Lodge DJ, (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30: 220-227. (Pubitemid 46654234)
17. Haile CN, During MJ, Jatlow PI, Kosten TR, Kosten TA, (2003) Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biol Psychiatry 54: 915-921. (Pubitemid 37311354)
18. Hameedi FA, Rosen MI, McCance-Katz EF, McMahon TJ, Price LH, Jatlow PI, Woods SW, Kosten TR, (1995) Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry 37: 560-563.
19. Heffner TG, Hartman JA, Seiden LS, (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13: 453-456. (Pubitemid 10008987)
20. 2 adrenoceptor blockade. Science 286: 105-107. (Pubitemid 29484485)
21. Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX, (1988) Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals. J Pharmacol Exp Ther 245: 761-772.
22. Karamanakos PN, Pappas P, Stephanou P, Marselos M, (2001) Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism. Pharmacol Toxicol 88: 106-110. (Pubitemid 32147088)
23. Lammel S, Hetzel A, Häckel O, Jones I, Liss B, Roeper J, (2008) Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57: 760-773. (Pubitemid 351335346)
24. 2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience 84: 1085-1096. (Pubitemid 28157025)
25. Lee B, Tiefenbacher S, Platt DM, Spealman RD, (2004) Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29: 686-693. (Pubitemid 38402476)
26. Masana M, Bortolozzi A, Artigas F, (2011) Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. Int J Neuropsychopharmacol 14: 53-68.
27. Masana M, Castañé A, Santana N, Bortolozzi A, Artigas F, (2012) Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies. Neuropharmacology 63: 675-684.
28. Matsumoto M, Yoshioka M, Togashi H, Mori K, Ueno K, Saito H, (1998) Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats. Eur J Pharmacol 343: 165-170. (Pubitemid 28138599)
29. McCance-Katz EF, Kosten TR, Jatlow P, (1998) Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone-a multiple-dose study. Biol Psychiatry 44: 250-259. (Pubitemid 28389710)
30. Musacchio JM, Goldstein M, Anagnoste B, Poch G, Kopin IJ, (1966) Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther 152: 56-61.
31. Mutschler J, Diehl A, Kiefer F, (2009) Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action. J Clin Psychopharmacol 29: 99-101.
32. Nousiainen U, Törrönen R, (1984) Differentiation of microsomal and cytosolic carboxylesterases in the rat liver by in vivo and in vitro inhibition. Gen Pharmacol 15: 223-227. (Pubitemid 14104076)
33. Ozaki N, Nakahara D, Miura H, Kasahara Y, Nagatsu T, (1989) Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method. J Neurochem 53: 1861-1864. (Pubitemid 19283657)
34. Paxinos G, Watson C, (1997) The Rat Brain in Stereotaxic Coordinates, 3rd edn. San Diego, CA: Academic Press.
35. Petrakis IL, Carroll KM, Nich C, Gordon LT, McCance-Katz EF, Frankforter T, Rounsaville BJ, (2000) Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 95: 219-228. (Pubitemid 30111242)
36. Plantjé JF, Steinbusch HW, Schipper J, Dijcks FA, Verheijden PF, Stoof JC, (1987) D-2 dopamine-receptors regulate the release of [3H]dopamine in rat cortical regions showing dopamine immunoreactive fibers. Neuroscience 20: 157-168. (Pubitemid 17015252)
37. Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R, (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem 63: 195-200. (Pubitemid 24184918)
38. Savolainen K, Hervonen H, Lehto VP, Mattila MJ, (1984) Neurotoxic effects of disulfiram on autonomic nervous system in rat. Acta Pharmacol Toxicol (Copenh) 55: 339-344. (Pubitemid 15179472)
39. Schroeder JP, Cooper DA, Schank JR, Lyle MA, Gaval-Cruz M, Ogbonmwan YE, Pozdeyev N, Freeman KG, Iuvone PM, Edwards GL, Holmes PV, Weinshenker D, (2010) Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. Neuropsychopharmacology 35: 2440-2449.
40. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI, (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18: 2697-2708. (Pubitemid 28141815)
41. Sofuoglu M, Kosten TR, (2006) Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs 11: 91-98.
42. Stanley WC, Li B, Bonhaus DW, Johnson LG, Lee K, Porter S, Walker K, Martinez G, Eglen RM, Whiting RL, Hegde SS, (1997) Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol 121: 1803-1809. (Pubitemid 27343414)
43. Sulzer D, Sonders MS, Poulsen NW, Galli A, (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75: 406-433. (Pubitemid 40834286)
44. Talmaciu RK, Hoffmann IS, Cubeddu LX, (1986) Dopamine autoreceptors modulate dopamine release from the prefrontal cortex. J Neurochem 47: 865-870. (Pubitemid 16029570)
45. Tam SY, Elsworth JD, Bradberry CW, Roth RH, (1990) Mesocortical dopamine neurons: high basal firing frequency predicts tyrosine dependence of dopamine synthesis. J Neural Transm Gen Sect 81: 97-110. (Pubitemid 20175065)
46. Torres GE, Gainetdinov RR, Caron MG, (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4: 13-25. (Pubitemid 37271085)
47. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S, (2003) Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23: 1879-1885. (Pubitemid 36321778)
48. 2 adrenoceptor blockade: experimental evidence. Int J Neuropsychopharmacol 10: 191-202.
49. Wallace LJ, (2012) Effects of amphetamine on subcellular distribution of dopamine and DOPAC. Synapse 66: 592-607.
50. Weinshenker D, Ferrucci M, Busceti CL, Biagioni F, Lazzeri G, Liles LC, Lenzi P, Pasquali L, Murri L, Paparelli A, Fornai F, (2008) Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine. J Neurochem 105: 471-483. (Pubitemid 351490013)
51. Weinshenker D, Schroeder JP, (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32: 1433-1451. (Pubitemid 46920149)
52. White FJ, Wang RY, (1984) A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci 34: 1161-1170. (Pubitemid 14161730)
53. Zemaitis MA, Greene FE, (1976) Impairment of hepatic microsomal drug metabolism in the rat during daily disulfiram administration. Biochem Pharmacol 25: 1355-1360.